4Blay JY, Lasset C, Carrie C, et al. Multivariate analysis of prognostic factors in patients with non HIV-related primary cerebral lymphoma. A proposal for a prognostic scoring. Br J Cancer, 1993,67:1136-1141.
5van der Sanden GA, Schouten LJ, van Dijck JA, et al. Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands. Cancer, 2002,94:1548-1556.
6Olson JE, Janney CA, Rao RD, et al. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer, 2002,95:1504-1510.
7Eby NL, Grufferman S, Flannelly CM, et al. Increasing incidence of primary brain lymphoma in the US. Cancer, 1988,62:2461-2465.
8Kadan-Lottick NS, Skluzacek MC, Gurney JG. Decreasing incidence rates of primary central nervous system lymphoma. Cancer, 2002,95:193-202.
9Feiden W, Milutinovic S. Primary CNS lymphomas. Morphology and diagnosis. Pathologe, 2002,23:284-291.
10Siegal T, Zylber-Katz E. Strategies for increasing drug delivery to the brain: focus on brain lymphoma. Clin Pharmacokinet, 2002,41:171-186.
